1 葛艳,刘福民,刘永利,等.TGF-β1与Foxp3蛋白在宫颈癌组织中表达意义及相互关系.中国生育健康杂志,2015,26:27-30. 2 崔张霞.紫杉醇联合顺铂方案对局部晚期宫颈癌患者MACC1及Ezrin蛋白表达的影响.现代医学,2017,45:59-62. 3 Kong J,Di C,Piao J,et al.Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition.Oncotarget,2016,7:19631-19642. 4 李丹,谢珊艳,刘怡安.Ezrin蛋白在宫颈癌中表达及其临床意义.中国妇幼保健,2015,30:775-778. 5 奚美丽,李俊,鹿欣.Ezrin蛋白在宫颈癌中表达的临床意义及其与PCNA、MMP-2、MMP-9、HPV E6蛋白的关系.中国癌症杂志,2013,23:904-907. 6 Bansal A,Das P,Kannan S,et al.Effect of p53 codon 72 polymorphism on the survival outcome in advanced stage cervical cancerpatients in India.Indian J Med Res,2016,144:359-365. 7 Hu J,Liu J,Chen A,et al.Ino80 promotes cervical cancer tumorigenesis by activating Nanog expression.Oncotarget,2016,7:72250-72262. 8 杨杏.p53和NF2基因甲基化在宫颈癌中研究进展.现代妇产科进展,2016,25:862-865. 9 于爱清,李成林,杨毅,等.TALENs介导的Nanog基因表达下调对宫颈癌Hela细胞恶性行为的影响.四川大学学报(医学版),2016,47:23-27. 10 Liu D,Zhou P,Zhang L,et al.HDAC1/DNMT3A-containing complex is associated with suppression of Oct4 in cervical cancer cells.Biochemistry (Mosc),2012,77:934-940. 11 Wang D,Li Q,Li K,et al.Twist-related protein 1-mediated regulation of mesenchymal change contributes to the migration and invasion of cervical cancer cells.Oncol Lett,2015,10:3107-3112. 12 田琴.宫颈癌及癌前病变组织中Twist及TB-1基因表达及与细胞侵袭的相关性.海南医学院学报,2017,23:437-440. 13 阚岩岩,张建华,周敏,等.下调Rab11基因对宫颈癌HeLa/SiHa细胞侵袭迁移的影响及机制探讨.中国癌症杂志,2016,26:238-245.
